Sichuan Dowell Science and Technology Inc. (300535.SZ) established a holding subsidiary, Bolian New Materials, to expand the company's product line.
Dawei Corporation (300535.SZ) announced that, in order to expand its chemical new materials product line, the company has jointly established Shanghai Dawei Bolian New Materials Co., Ltd. with Mr. Zhou Shuai (hereinafter referred to as "Bolian New Materials") with a registered capital of 5.5 million yuan. The company subscribed for 3.3 million yuan, accounting for 60%, in the form of physical or cash contributions; Mr. Zhou subscribed for 2.2 million yuan, accounting for 40%, in the form of intangible assets such as product research and development, production, and technology. The company's funds come from self-raised funds. Bolian New Materials' main products include chemical additives for automotive interior materials, crosslinking agents for leather coatings, and chemicals for electronic materials.
Sichuan Dowell Science and Technology Inc. (300535.SZ) announced that in order to expand its chemical new materials product line, the company has jointly established Shanghai Dawei Bolian New Materials Co., Ltd. (hereinafter referred to as "Bolian New Materials") with Mr. Zhou Shuai. The registered capital is 5.5 million yuan, with the company subscribing for 3.3 million yuan, accounting for 60%, and the investment method is in-kind or cash contribution; Mr. Zhou Shuai subscribes for 2.2 million yuan, accounting for 40%, contributing intangible assets such as R&D, production, and technology of the products. The company's funds come from self-raised funds.
Bolian New Materials' main products are chemical additives for automotive interior materials, crosslinkers for leather coatings, and chemicals for electronic materials.
The purpose of this investment is to broaden the company's product line, improve the product series of automotive interior materials and coating crosslinkers, enhance the perfection and upgrade of the existing product line, and strengthen the core competitiveness of the company's chemical main business. At the same time, considering the company's long-term development strategy, it can help the company quickly expand into new business areas, accelerate the company's industrial layout, seize the first-mover advantage in the new materials market, enhance the company's comprehensive profitability, and further improve the company's economic efficiency.
Related Articles
CF PHARAMTECH (02652) spent 1.9159 million Hong Kong dollars on May 22 to repurchase 100,000 shares.
CULTURECOM HOLD (00343) successfully issued 65.419 million shares, raising approximately 68.9 million Hong Kong dollars net.
DT Capital (00356) is planning to issue 285.7 million subscription shares to the public trading globally at a discount of approximately 14.04%, raising net proceeds of approximately HK$13.89 million.
CF PHARAMTECH (02652) spent 1.9159 million Hong Kong dollars on May 22 to repurchase 100,000 shares.
CULTURECOM HOLD (00343) successfully issued 65.419 million shares, raising approximately 68.9 million Hong Kong dollars net.
DT Capital (00356) is planning to issue 285.7 million subscription shares to the public trading globally at a discount of approximately 14.04%, raising net proceeds of approximately HK$13.89 million.
